Global Autoimmune Disease Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Autoimmune Disease Diagnostics market size is estimated to be worth US$ 5048.5 million in 2021 and is forecast to a readjusted size of USD 6864.9 million by 2028 with a CAGR of 4.5% during review period. Hospitals accounting for % of the Autoimmune Disease Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Analyzers segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Autoimmune Disease Diagnostics include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, EUROIMMUN, and Inova Diagnostics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Autoimmune Disease Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analyzers
Assay Kits
Market segment by Application, can be divided into
Hospitals
Research Laboratories
Market segment by players, this report covers
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Autoimmune Disease Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Autoimmune Disease Diagnostics, with revenue, gross margin and global market share of Autoimmune Disease Diagnostics from 2019 to 2022.
Chapter 3, the Autoimmune Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Autoimmune Disease Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Autoimmune Disease Diagnostics research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Autoimmune Disease Diagnostics
1.2 Classification of Autoimmune Disease Diagnostics by Type
1.2.1 Overview: Global Autoimmune Disease Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Type in 2021
1.2.3 Analyzers
1.2.4 Assay Kits
1.3 Global Autoimmune Disease Diagnostics Market by Application
1.3.1 Overview: Global Autoimmune Disease Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Global Autoimmune Disease Diagnostics Market Size & Forecast
1.5 Global Autoimmune Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Autoimmune Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Autoimmune Disease Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Autoimmune Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Autoimmune Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Autoimmune Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Autoimmune Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Autoimmune Disease Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Autoimmune Disease Diagnostics Market Drivers
1.6.2 Autoimmune Disease Diagnostics Market Restraints
1.6.3 Autoimmune Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Product and Solutions
2.1.4 Abbott Laboratories Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Autoimmune Disease Diagnostics Product and Solutions
2.2.4 Beckman Coulter Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product and Solutions
2.3.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 EUROIMMUN
2.4.1 EUROIMMUN Details
2.4.2 EUROIMMUN Major Business
2.4.3 EUROIMMUN Autoimmune Disease Diagnostics Product and Solutions
2.4.4 EUROIMMUN Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 EUROIMMUN Recent Developments and Future Plans
2.5 Inova Diagnostics
2.5.1 Inova Diagnostics Details
2.5.2 Inova Diagnostics Major Business
2.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.5.4 Inova Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Inova Diagnostics Recent Developments and Future Plans
2.6 Roche Diagnostics
2.6.1 Roche Diagnostics Details
2.6.2 Roche Diagnostics Major Business
2.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.6.4 Roche Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Roche Diagnostics Recent Developments and Future Plans
2.7 Siemens Healthcare
2.7.1 Siemens Healthcare Details
2.7.2 Siemens Healthcare Major Business
2.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Product and Solutions
2.7.4 Siemens Healthcare Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Siemens Healthcare Recent Developments and Future Plans
2.8 DiaSorin
2.8.1 DiaSorin Details
2.8.2 DiaSorin Major Business
2.8.3 DiaSorin Autoimmune Disease Diagnostics Product and Solutions
2.8.4 DiaSorin Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 DiaSorin Recent Developments and Future Plans
2.9 ERBA Diagnostics
2.9.1 ERBA Diagnostics Details
2.9.2 ERBA Diagnostics Major Business
2.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.9.4 ERBA Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ERBA Diagnostics Recent Developments and Future Plans
2.10 Euro Diagnostica
2.10.1 Euro Diagnostica Details
2.10.2 Euro Diagnostica Major Business
2.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Product and Solutions
2.10.4 Euro Diagnostica Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Euro Diagnostica Recent Developments and Future Plans
2.11 Autoimmune Technologies
2.11.1 Autoimmune Technologies Details
2.11.2 Autoimmune Technologies Major Business
2.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Product and Solutions
2.11.4 Autoimmune Technologies Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Autoimmune Technologies Recent Developments and Future Plans
2.12 Avant Diagnostics
2.12.1 Avant Diagnostics Details
2.12.2 Avant Diagnostics Major Business
2.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.12.4 Avant Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Avant Diagnostics Recent Developments and Future Plans
2.13 Exagen Diagnostics
2.13.1 Exagen Diagnostics Details
2.13.2 Exagen Diagnostics Major Business
2.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.13.4 Exagen Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Exagen Diagnostics Recent Developments and Future Plans
2.14 Gold Standard Diagnostics
2.14.1 Gold Standard Diagnostics Details
2.14.2 Gold Standard Diagnostics Major Business
2.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.14.4 Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Gold Standard Diagnostics Recent Developments and Future Plans
2.15 HOB Diagnostics
2.15.1 HOB Diagnostics Details
2.15.2 HOB Diagnostics Major Business
2.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.15.4 HOB Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 HOB Diagnostics Recent Developments and Future Plans
2.16 HUMAN Diagnostics
2.16.1 HUMAN Diagnostics Details
2.16.2 HUMAN Diagnostics Major Business
2.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.16.4 HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 HUMAN Diagnostics Recent Developments and Future Plans
2.17 Immco Diagnostics
2.17.1 Immco Diagnostics Details
2.17.2 Immco Diagnostics Major Business
2.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.17.4 Immco Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Immco Diagnostics Recent Developments and Future Plans
2.18 ImmunArray
2.18.1 ImmunArray Details
2.18.2 ImmunArray Major Business
2.18.3 ImmunArray Autoimmune Disease Diagnostics Product and Solutions
2.18.4 ImmunArray Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 ImmunArray Recent Developments and Future Plans
2.19 Myriad Genetics
2.19.1 Myriad Genetics Details
2.19.2 Myriad Genetics Major Business
2.19.3 Myriad Genetics Autoimmune Disease Diagnostics Product and Solutions
2.19.4 Myriad Genetics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Myriad Genetics Recent Developments and Future Plans
2.20 Omega Diagnostics
2.20.1 Omega Diagnostics Details
2.20.2 Omega Diagnostics Major Business
2.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Product and Solutions
2.20.4 Omega Diagnostics Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Omega Diagnostics Recent Developments and Future Plans
2.21 ORGENTEC Diagnostika
2.21.1 ORGENTEC Diagnostika Details
2.21.2 ORGENTEC Diagnostika Major Business
2.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product and Solutions
2.21.4 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 ORGENTEC Diagnostika Recent Developments and Future Plans
2.22 Phadia
2.22.1 Phadia Details
2.22.2 Phadia Major Business
2.22.3 Phadia Autoimmune Disease Diagnostics Product and Solutions
2.22.4 Phadia Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Phadia Recent Developments and Future Plans
2.23 Protagen
2.23.1 Protagen Details
2.23.2 Protagen Major Business
2.23.3 Protagen Autoimmune Disease Diagnostics Product and Solutions
2.23.4 Protagen Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 Protagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Autoimmune Disease Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Autoimmune Disease Diagnostics Players Market Share in 2021
3.2.2 Top 10 Autoimmune Disease Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Autoimmune Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Autoimmune Disease Diagnostics Mergers & Acquisitions
3.5 Autoimmune Disease Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Autoimmune Disease Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Autoimmune Disease Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Autoimmune Disease Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Autoimmune Disease Diagnostics Revenue by Type (2017-2028)
6.2 North America Autoimmune Disease Diagnostics Revenue by Application (2017-2028)
6.3 North America Autoimmune Disease Diagnostics Market Size by Country
6.3.1 North America Autoimmune Disease Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Autoimmune Disease Diagnostics Revenue by Type (2017-2028)
7.2 Europe Autoimmune Disease Diagnostics Revenue by Application (2017-2028)
7.3 Europe Autoimmune Disease Diagnostics Market Size by Country
7.3.1 Europe Autoimmune Disease Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Autoimmune Disease Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Autoimmune Disease Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Autoimmune Disease Diagnostics Revenue by Region (2017-2028)
8.3.2 China Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Autoimmune Disease Diagnostics Revenue by Type (2017-2028)
9.2 South America Autoimmune Disease Diagnostics Revenue by Application (2017-2028)
9.3 South America Autoimmune Disease Diagnostics Market Size by Country
9.3.1 South America Autoimmune Disease Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Autoimmune Disease Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Autoimmune Disease Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Autoimmune Disease Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Autoimmune Disease Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Autoimmune Disease Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Autoimmune Disease Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Autoimmune Disease Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Autoimmune Disease Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Autoimmune Disease Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Autoimmune Disease Diagnostics Product and Solutions
Table 9. Abbott Laboratories Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 11. Beckman Coulter Major Business
Table 12. Beckman Coulter Autoimmune Disease Diagnostics Product and Solutions
Table 13. Beckman Coulter Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product and Solutions
Table 17. Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. EUROIMMUN Corporate Information, Head Office, and Major Competitors
Table 19. EUROIMMUN Major Business
Table 20. EUROIMMUN Autoimmune Disease Diagnostics Product and Solutions
Table 21. EUROIMMUN Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Inova Diagnostics Corporate Information, Head Office, and Major Competitors
Table 23. Inova Diagnostics Major Business
Table 24. Inova Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 25. Inova Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 27. Roche Diagnostics Major Business
Table 28. Roche Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 29. Roche Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 31. Siemens Healthcare Major Business
Table 32. Siemens Healthcare Autoimmune Disease Diagnostics Product and Solutions
Table 33. Siemens Healthcare Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 35. DiaSorin Major Business
Table 36. DiaSorin Autoimmune Disease Diagnostics Product and Solutions
Table 37. DiaSorin Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ERBA Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. ERBA Diagnostics Major Business
Table 40. ERBA Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 41. ERBA Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Euro Diagnostica Corporate Information, Head Office, and Major Competitors
Table 43. Euro Diagnostica Major Business
Table 44. Euro Diagnostica Autoimmune Disease Diagnostics Product and Solutions
Table 45. Euro Diagnostica Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Autoimmune Technologies Corporate Information, Head Office, and Major Competitors
Table 47. Autoimmune Technologies Major Business
Table 48. Autoimmune Technologies Autoimmune Disease Diagnostics Product and Solutions
Table 49. Autoimmune Technologies Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Avant Diagnostics Corporate Information, Head Office, and Major Competitors
Table 51. Avant Diagnostics Major Business
Table 52. Avant Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 53. Avant Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Exagen Diagnostics Corporate Information, Head Office, and Major Competitors
Table 55. Exagen Diagnostics Major Business
Table 56. Exagen Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 57. Exagen Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Gold Standard Diagnostics Corporate Information, Head Office, and Major Competitors
Table 59. Gold Standard Diagnostics Major Business
Table 60. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 61. Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. HOB Diagnostics Corporate Information, Head Office, and Major Competitors
Table 63. HOB Diagnostics Major Business
Table 64. HOB Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 65. HOB Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. HUMAN Diagnostics Corporate Information, Head Office, and Major Competitors
Table 67. HUMAN Diagnostics Major Business
Table 68. HUMAN Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 69. HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Immco Diagnostics Corporate Information, Head Office, and Major Competitors
Table 71. Immco Diagnostics Major Business
Table 72. Immco Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 73. Immco Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. ImmunArray Corporate Information, Head Office, and Major Competitors
Table 75. ImmunArray Major Business
Table 76. ImmunArray Autoimmune Disease Diagnostics Product and Solutions
Table 77. ImmunArray Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 79. Myriad Genetics Major Business
Table 80. Myriad Genetics Autoimmune Disease Diagnostics Product and Solutions
Table 81. Myriad Genetics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Omega Diagnostics Corporate Information, Head Office, and Major Competitors
Table 83. Omega Diagnostics Major Business
Table 84. Omega Diagnostics Autoimmune Disease Diagnostics Product and Solutions
Table 85. Omega Diagnostics Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. ORGENTEC Diagnostika Corporate Information, Head Office, and Major Competitors
Table 87. ORGENTEC Diagnostika Major Business
Table 88. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product and Solutions
Table 89. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Phadia Corporate Information, Head Office, and Major Competitors
Table 91. Phadia Major Business
Table 92. Phadia Autoimmune Disease Diagnostics Product and Solutions
Table 93. Phadia Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Protagen Corporate Information, Head Office, and Major Competitors
Table 95. Protagen Major Business
Table 96. Protagen Autoimmune Disease Diagnostics Product and Solutions
Table 97. Protagen Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Global Autoimmune Disease Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 99. Global Autoimmune Disease Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 100. Breakdown of Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 101. Autoimmune Disease Diagnostics Players Head Office, Products and Services Provided
Table 102. Autoimmune Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 103. Autoimmune Disease Diagnostics New Entrants and Expansion Plans
Table 104. Global Autoimmune Disease Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 105. Global Autoimmune Disease Diagnostics Revenue Share by Type (2017-2022)
Table 106. Global Autoimmune Disease Diagnostics Revenue Forecast by Type (2023-2028)
Table 107. Global Autoimmune Disease Diagnostics Revenue by Application (2017-2022)
Table 108. Global Autoimmune Disease Diagnostics Revenue Forecast by Application (2023-2028)
Table 109. North America Autoimmune Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 110. North America Autoimmune Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 111. North America Autoimmune Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 112. North America Autoimmune Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 113. North America Autoimmune Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 114. North America Autoimmune Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 115. Europe Autoimmune Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 116. Europe Autoimmune Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 117. Europe Autoimmune Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 118. Europe Autoimmune Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 119. Europe Autoimmune Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 120. Europe Autoimmune Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 121. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 122. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 123. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 124. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 125. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 126. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 127. South America Autoimmune Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 128. South America Autoimmune Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 129. South America Autoimmune Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 130. South America Autoimmune Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 131. South America Autoimmune Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 132. South America Autoimmune Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 133. Middle East & Africa Autoimmune Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 134. Middle East & Africa Autoimmune Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 135. Middle East & Africa Autoimmune Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 136. Middle East & Africa Autoimmune Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 137. Middle East & Africa Autoimmune Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 138. Middle East & Africa Autoimmune Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Autoimmune Disease Diagnostics Picture
Figure 2. Global Autoimmune Disease Diagnostics Revenue Market Share by Type in 2021
Figure 3. Analyzers
Figure 4. Assay Kits
Figure 5. Autoimmune Disease Diagnostics Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Research Laboratories Picture
Figure 8. Global Autoimmune Disease Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Autoimmune Disease Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Autoimmune Disease Diagnostics Revenue Market Share by Region (2017-2028)
Figure 11. Global Autoimmune Disease Diagnostics Revenue Market Share by Region in 2021
Figure 12. North America Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Autoimmune Disease Diagnostics Market Drivers
Figure 18. Autoimmune Disease Diagnostics Market Restraints
Figure 19. Autoimmune Disease Diagnostics Market Trends
Figure 20. Abbott Laboratories Recent Developments and Future Plans
Figure 21. Beckman Coulter Recent Developments and Future Plans
Figure 22. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 23. EUROIMMUN Recent Developments and Future Plans
Figure 24. Inova Diagnostics Recent Developments and Future Plans
Figure 25. Roche Diagnostics Recent Developments and Future Plans
Figure 26. Siemens Healthcare Recent Developments and Future Plans
Figure 27. DiaSorin Recent Developments and Future Plans
Figure 28. ERBA Diagnostics Recent Developments and Future Plans
Figure 29. Euro Diagnostica Recent Developments and Future Plans
Figure 30. Autoimmune Technologies Recent Developments and Future Plans
Figure 31. Avant Diagnostics Recent Developments and Future Plans
Figure 32. Exagen Diagnostics Recent Developments and Future Plans
Figure 33. Gold Standard Diagnostics Recent Developments and Future Plans
Figure 34. HOB Diagnostics Recent Developments and Future Plans
Figure 35. HUMAN Diagnostics Recent Developments and Future Plans
Figure 36. Immco Diagnostics Recent Developments and Future Plans
Figure 37. ImmunArray Recent Developments and Future Plans
Figure 38. Myriad Genetics Recent Developments and Future Plans
Figure 39. Omega Diagnostics Recent Developments and Future Plans
Figure 40. ORGENTEC Diagnostika Recent Developments and Future Plans
Figure 41. Phadia Recent Developments and Future Plans
Figure 42. Protagen Recent Developments and Future Plans
Figure 43. Global Autoimmune Disease Diagnostics Revenue Share by Players in 2021
Figure 44. Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 45. Global Top 3 Players Autoimmune Disease Diagnostics Revenue Market Share in 2021
Figure 46. Global Top 10 Players Autoimmune Disease Diagnostics Revenue Market Share in 2021
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 48. Global Autoimmune Disease Diagnostics Revenue Share by Type in 2021
Figure 49. Global Autoimmune Disease Diagnostics Market Share Forecast by Type (2023-2028)
Figure 50. Global Autoimmune Disease Diagnostics Revenue Share by Application in 2021
Figure 51. Global Autoimmune Disease Diagnostics Market Share Forecast by Application (2023-2028)
Figure 52. North America Autoimmune Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 53. North America Autoimmune Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 54. North America Autoimmune Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 55. United States Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Canada Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Mexico Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Europe Autoimmune Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 59. Europe Autoimmune Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 60. Europe Autoimmune Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 61. Germany Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. France Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. United Kingdom Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Russia Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Italy Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Asia-Pacific Autoimmune Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 67. Asia-Pacific Autoimmune Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 68. Asia-Pacific Autoimmune Disease Diagnostics Revenue Market Share by Region (2017-2028)
Figure 69. China Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Japan Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South Korea Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. India Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Southeast Asia Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Australia Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South America Autoimmune Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 76. South America Autoimmune Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 77. South America Autoimmune Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 78. Brazil Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Argentina Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Middle East and Africa Autoimmune Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Autoimmune Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Autoimmune Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 83. Turkey Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Saudi Arabia Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. UAE Autoimmune Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
